4
Changes in Ownership
Milestone Pharmaceuticals Inc. Filed Acc 0001437782-26-000004
President and CEO sold 167,577 shares at an average $2.24 ($375,315)
- President and CEO acquired 280,000 shares (grant or award)
- President and CEO acquired 66,600 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Oliveto Joseph · President and CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-12 | Grant or award : show line 1 in the form | +280,000 | 583,721 | D | ||
| 2025-12-15 | Sale : show line 2 in the form | −133,054 | $2.32 | $308,685 | 450,667 | D |
| 2026-01-26 | Exercise or conversion : show line 3 in the form | +66,600 | 517,267 | D | ||
| 2026-01-26 | Sale : show line 4 in the form | −34,523 | $1.93 | $66,629 | 482,744 | D |
| Open-market sales · 167,577 sh · avg $2.24 · $375,315 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-12 | Grant or award : show line 5 in the form Employee Stock Option (right to buy) | +280,000 | 280,000 | D |
| 2026-01-26 | Exercise or conversion : show line 6 in the form Restricted Stock Units | −66,600 | 199,800 | D |
Loading xslF345X05/form4-01282026_060101.xml…